Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features

被引:1
作者
Tariq, Muhammad Usman [1 ]
Siddiqui, Muhammad Afnan [2 ]
Din, Nasir Ud [3 ]
Kayani, Naila [3 ]
机构
[1] Al Hada Armed Forces Hosp, Histopathol, Taif, Saudi Arabia
[2] Indus Hosp & Hlth Network, Histopathol, Karachi, Pakistan
[3] Aga Khan Univ Hosp, Pathol & Lab Med, Karachi, Pakistan
关键词
tumor infiltrating lymphocytes; immunohistochemistry; tnbc; triple negative breast cancer; sox10; MELANOCYTIC NEOPLASMS; CARCINOMA; FREQUENCY; UTILITY;
D O I
10.7759/cureus.59276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Triple -negative breast cancer (TNBC) poses a diagnostic challenge for histopathologists due to the reduced frequency of breast -specific markers. SOX10 has emerged as a useful diagnostic marker for TNBC. The aim of our study was to determine the frequency of SOX -10 immunohistochemical (IHC) expression in our cohort and assess its correlation with clinicopathological and histological features. Materials and methods: We included 72 primary TNBC cases. Specimens included tru-cut biopsies and excision specimens. We stained whole slide sections of these specimens with SOX10 antibody and calculated its frequency (%) of expression and H -score. We applied the chi-square test to assess the correlation between SOX10 expression and clinicopathological and histological features such as the patient's age, specimen type, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, tumor -infiltrating lymphocytes (TILs), necrosis, calcification, lymphovascular invasion (LVI), lymph node involvement, T stage, and N stage. Results: SOX10 expression was observed in 42 (58.3%) cases with a median H -score of 57.5. The expression was significantly higher in tru-cut biopsy specimens as compared to excision specimens (73.5 vs 41.7%) and TILs negative tumors as compared to TILs positive tumors (64.3% vs 27.3). Metaplastic carcinoma showed reduced expression when compared with non-metaplastic tumors (35.7% vs 63.8%), but statistical significance was not achieved. No correlation was observed with the patient's age, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, necrosis, calcification, LVI, lymph node involvement, T stage, and N stage. Conclusion: SOX10 was expressed in more than half of the TNBC cases of our study which not only highlights its diagnostic utility but advocated its application in combination with other breast -specific markers. The expression didn't correlate with the majority of clinicopathological and histological features, but correlation with tru-cut biopsy specimens and absence of TILs draws attention towards possible roles of proper fixation and host immunity, respectively.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients
    Dogukan, Rabia
    Ucak, Ramazan
    Dogukan, Fatih Mert
    Tanik, Canan
    Citgez, Bulent
    Kabukcuoglu, Fevziye
    EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (04) : 235 - 241
  • [22] Clinicopathological features of triple-negative breast cancer in Taiwanese women
    Kuo Yao-Lung
    Chen Dar-Ren
    Chang Tsai-Wang
    International Journal of Clinical Oncology, 2011, 16 : 500 - 505
  • [23] Clinicopathological features of triple-negative breast cancer in Taiwanese women
    Kuo Yao-Lung
    Chen Dar-Ren
    Chang Tsai-Wang
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) : 500 - 505
  • [24] Clinicopathological features and treatment strategy for triple-negative breast cancer
    Yutaka Yamamoto
    Hirotaka Iwase
    International Journal of Clinical Oncology, 2010, 15 : 341 - 351
  • [25] Clinicopathological features and treatment strategy for triple-negative breast cancer
    Yamamoto, Yutaka
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 341 - 351
  • [26] Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
    Qiu, Jingdan
    Xue, Xinying
    Hu, Chao
    Xu, Hu
    Kou, Deqiang
    Li, Rong
    Li, Ming
    JOURNAL OF CANCER, 2016, 7 (02): : 167 - 173
  • [27] SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma
    Laurent, Elodie
    Begueret, Hugues
    Bonhomme, Benjamin
    Veillon, Remi
    Thumerel, Matthieu
    Velasco, Valerie
    Brouste, Veronique
    Hoppe, Stephanie
    Fournier, Marion
    Grellety, Thomas
    MacGrogan, Gaetan
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (03) : 293 - 302
  • [28] The Added Value of SOX10 Immunohistochemistry to Other Breast Markers in Identifying Cytokeratin 5-Positive Triple Negative Breast Cancers as of Mammary Origin
    Sejben, Anita
    Voros, Andras
    Golan, Arbel
    Zombori, Tamas
    Cserni, Gabor
    PATHOBIOLOGY, 2021, 88 (03) : 228 - 233
  • [29] Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
    Thike, Aye Aye
    Iqbal, Jabed
    Cheok, Poh Yian
    Chong, Angela Phek Yoon
    Tse, Gary Man-Kit
    Tan, Benita
    Tan, Patrick
    Wong, Nan Soon
    Tan, Puay Hoon
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (07) : 956 - 964
  • [30] Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer
    Schaefer, Sarah Alexandra
    Huelsewig, Carolin
    Barth, Peter
    von Wahlde, Marie-Kristin
    Tio, Joke
    Kolberg, Hans-Christian
    Bernemann, Christof
    Blohmer, Jens-Uwe
    Kiesel, Ludwig
    Kolberg-Liedtke, Cornelia
    FUTURE ONCOLOGY, 2019, 15 (16) : 1921 - 1938